BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20426783)

  • 1. Chilblains and antiphospholipid antibodies: report of four cases and review of the literature.
    Lutz V; Cribier B; Lipsker D
    Br J Dermatol; 2010 Sep; 163(3):645-6. PubMed ID: 20426783
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunopathology of the antiphospholipid syndrome].
    Stojanović Lj; Alekbergova Z; Kalasnikova Lj; Nasonov E; Manujlova L; Sokolov V; Stanić M
    Srp Arh Celok Lek; 1994; 122 Suppl 1():53-6. PubMed ID: 18173188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiphospholipid syndrome].
    Obernosterer A; Pilger E; Auer-Grumbach P; Tischler R; Doder A; Lafer M; Decrinis M
    Vasa Suppl; 1992; 37():43-4. PubMed ID: 1481096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic lupus erythematosus. Anti-phospholipid syndrome].
    Fain O
    Rev Prat; 2008 Nov; 58(17):1935-42. PubMed ID: 19157212
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiphospholipid syndrome--the description of two cases].
    Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
    Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical relevance of antiphospholipid antibodies in rheumatology].
    Gromnica-Ihle E; Franz J
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):525-9. PubMed ID: 7856256
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary lethal catastrophic antiphospholipid syndrome in 24-years old female patient with overlap syndrome (systemic sclerosis and systemic lupus erythematosus)].
    Ciołkiewicz M; Domysławska I; Kita K; Muklewicz E; Kowal-Bielecka O; Lewandowski B; Sierakowski S
    Pol Merkur Lekarski; 2006 Mar; 20(117):337-40. PubMed ID: 16780270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiphospholipid syndrome and psychosis].
    Clervoy P; Bonnot O; Verrot D; Nicand E; Devillières P; Ameil O; Lauwerier L
    Encephale; 1997; 23(2):105-7. PubMed ID: 9264928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-phospholipid syndrome nephropathy].
    Nochy D; Daugas E; Hill G; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic lupus erythematosus with neurologic onset and secondary antiphospholipid syndrome. A Case Study].
    Dima-Cozma C; Pandele GI; Rezuş E; Constantinescu A; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):254-8. PubMed ID: 16607781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y; Meroni PL; Toubi E
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The heterogeneity of systemic lupus erythematosus due to the antiphospholipid syndrome].
    Alekberova ZS; Nasonov EL; Stoianovich LZ
    Ter Arkh; 1992; 64(5):77-9. PubMed ID: 1455383
    [No Abstract]   [Full Text] [Related]  

  • 15. [The antiphospholipid syndrome].
    Meurer M
    Hautarzt; 1994 Oct; 45(10):729-38; quiz 737. PubMed ID: 8002345
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
    Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M
    Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.
    Asherson RA; Lioté F; Page B; Meyer O; Buchanan N; Khamashta MA; Jungers P; Hughes GR
    J Rheumatol; 1993 Feb; 20(2):284-8. PubMed ID: 8474066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
    Naarendorp M; Spiera H
    J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.